Golam Mohi

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Mesenchymal Stem Cells

Transforming Growth Factor

Top Venues

Cancer research

Blood cancer journal

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Yue Yang, Salar Abbas, Mohammad Abu Sayem, Avik Dutta, Golam Mohi
SRSF2 mutation reduces polycythemia and impairs hematopoietic progenitor functions in JAK2V617F-driven myeloproliferative neoplasm. Blood cancer journal 13 (1) (2023)
Mohammed Ferdous-Ur Rahman, Yue Yang, Bao T Le, Avik Dutta, Julia Posyniak, Patrick Faughnan, Mohammad Abu Sayem, Nadine S Aguilera, Golam Mohi
Interleukin-1 contributes to clonal expansion and progression of bone marrow fibrosis in JAK2V617F-induced myeloproliferative neoplasm. Nature communications 13 (1) (2022)
Avik Dutta, Dipmoy Nath, Yue Yang, Bao T Le, Mohammad Ferdous-Ur Rahman, Patrick Faughnan, Zhenjia Wang, Matthew Stuver, Rongquan He, Wuwei Tan, Robert E Hutchison, Jason M Foulks, Steven L Warner, Chongzhi Zang, Golam Mohi
Genetic ablation of Pim1 or pharmacologic inhibition with TP-3654 ameliorates myelofibrosis in murine models. Leukemia (2021)
Avik Dutta, Yue Yang, Bao T Le, Yifan Zhang, Omar Abdel-Wahab, Chongzhi Zang, Golam Mohi
U2af1 is required for survival and function of hematopoietic stem/progenitor cells. Leukemia 35 (8) (2021)
Avik Dutta, Dipmoy Nath, Yue Yang, Bao T Le, Golam Mohi
CDK6 Is a Therapeutic Target in Myelofibrosis. Cancer research 81 (16) (2021)